Loss of the Protein Cystathionine β-Synthase During Kidney Injury Promotes Renal Tubulointerstitial Fibrosis

Conclusions: These findings establish CBS as a novel inhibitor in renal fibrosis and as a new therapeutic target in patients with chronic kidney disease.Kidney Blood Press Res 2017;42:428 –443

Source: Kidney and Blood Pressure Research - July 27, 2017 Category: Urology & Nephrology Source Type: research